eso logo

safe logo

APPENDIX 1.

Members of the working group

The Steering Committee consisted of Bo Norrving (chair; Lund, Sweden), Valeria Caso (co-chair; Perugia, Italy), Martin Dichgans (Munich, Germany), Joanna M Wardlaw (Edinburgh, UK), Jill Farrington (World Health Organisation, Copenhagen, Denmark), Charlotte Cordonnier (Lille, France), Robert Mikulik (Brno, Czech Republic), Alla Guekht (Moscow, Russia), Antonio Davalos (Girona, Spain), Kursad Kutluk (Izmir, Turkey), and Jon Barrick (London, UK).

Members of the ESAP working groups were as follows. Primary prevention: Edo Richard (Chair), Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, and Department of Neurology, Academic Medical Centre, Amsterdam, the Netherlands; Eivind Berge, Departments of Internal Medicine and Cardiology, Oslo University Hospital, Oslo, Norway; Catarina Fonseca, Hospital de Santa Maria, University of Lisbon, Lisbon, Portugal; Richard Hobbs, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK; Stefan Kiechl, Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria; Patrik Michel, Stroke Center, Neurology Service, Lausanne University Hospital, Lausanne, Switzerland; Jelena Misita, Stroke  Alliance  For  Europe, Brussels, Belgium; Violetta Mkrtchyan, Research and Clinical Center for Neuropsychiatry of Moscow Moscow, Russia; Peter Rothwell,* Centre for Prevention of Stroke and Dementia, University of Oxford, Oxford, UK;  and Jaakko Tuomilehto,* National Institute for Health and Welfare, Helsinki, Finland. Organization of stroke services: Darius Nabavi (Chair), Department of Neurology, Vivantes Hospital Neukölln, Berlin, Germany;  Hanne Christensen,*Bispebjerg Hospital and University of Copenhagen, Copenhagen, Denmark; Miquel Gallofré, Stroke Program of Catalonia, Barcelona, Spain; Christian Gerloff, Department of Neurology, University Medical Center Hamburg Eppendorf (UKE), Hamburg, Germany; Damian Jenkinson, Dorset County Hospital NHS Foundation Trust, Dorchester, UK; Aleksandra Pavlovic, Faculty of Medicine, University of Belgrade, Belgrade, Serbia; Thorsten Steiner, Department of Neurology, Klinikum Frankfurt Höchst, Frankfurt, and Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany; Danilo Toni, Department of Human Neurosciences, University La Sapienza, Rome, Italy; Alexander Tsiskaridze,* Department of Neurology, Ivane Javakhishvili Tbilisi State University, Tbilisi, Georgia; and Georgios Tsivgoulis, Second Department of Neurology, Attikon University Hospital, National and Kapodistrian University of Athens, Athens, Greece. Management of acute stroke: Carlos A Molina (Chair), Department of Neurology, Hospital Vall d´Hebron Barcelona, Barcelona, Spain; Anita Arsovska, University Clinic of Neurology, University Ss Cyril and Methodius, Skopje, Macedonia; Heinrich Audebert, Center for Stroke Research Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany; Urs Fischer, Department of Neurology, University Hospital Bern, University of Bern, Switzerland; Zuzana Gdovinova, Department of Neurology, Faculty of Medicine, PJ Šafárik University and Univerity Hospital L Pasteur, Kosice, Slovakia; Werner Hacke,* University of Heidelberg, Heidelberg, Germany; Catharina JM (Karin) Klijn,* Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands; Kennedy R Lees,Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK; Mikael Mazighi, Lariboisière Hospital and Fondation Rothschild Hospital, Paris, France; and Bart van der Worp, Department of Neurology and Neurosurgery, University Medical Center Utrecht, Utrecht, the Netherlands. Secondary prevention and follow-up: Philip  Bath (Chair), Stroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, Nottingham, UK; Zauresh Akhmetzhanova, National Centre for Neurosurgery, Astana, Republic of Kazakhstan; Hugues Chabriat, Department of Neurology, Hopital Lariboisiére, Université Denis Diderot, Paris, France; Frank-Erik de Leeuw, Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, the Netherlands; Hans-Christoph Diener, Department of Neurology, University Hospital Essen, Essen, Germany; Jean-Louis Mas,* Department of Neurology, Hôpital Sainte-Anne,  Université Paris Descartes, Paris, France; Ivan Milojevic, Department of Neurology, Ćuprija, Serbia; Serefnur Ozturk, Faculty of Medicine, Selcuk University, Konya, Turkey; Maurizio Paciaroni,* Stroke Unit and Division of Cardiovascular Medicine, Santa Maria della Misericordia Hospital, University of Perugia, Perugia, Italy; and Alastair Webb, Centre for Prevention of Stroke and Dementia, University of Oxford, Oxford, UK. Rehabilitation: Katharina Stibrant Sunnerhagen (Chair), Institute of Neuroscience and Physiology, Sahlgrenska University Hospital, Gothenburg, Sweden; Michael Brainin, Danube University, Krems, Austria; Jesse Dawson,* Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK; Peter Langhorne, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK; Didier Leys, Inserm U1171, Univ-Lille, CHU Lille, Lille, France; Monique Lindhout, Stroke Alliance for Europe/Dutch Brain Injury Association (Hersenletsel.nl), Velp, the Netherlands; Andreas Luft, University Hospital Zurich and Cereneo Center for Neurology and Rehabilitation, Vitznau, Switzerland; Gillian Mead, University of Edinburgh, Edinburgh, UK; Jan Mehrholz, Technical University Dresden, Faculty of Medicine, Dresden, Germany; and Marion Walker,* Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, UK. Evaluation of outcomes and quality: Anthony Rudd (Chair), Guy's and St Thomas' NHS Foundation Trust and National Clinical Director for Stroke NHS England, London, UK; Sonia Abilleira, Stroke Programme/ Agency for Health Quality and Assessment of Catalonia, Barcelona, Spain; Yannick Béjot, Dijon Stroke Registry, University Hospital and Medical School of Dijon, University of Burgundy, Dijon, France; André de Rosa Spierings, Stroke Alliance For Europe (SAFE) / Hersenletsel.nl, Velp, the Netherlands; Marie Eriksson,* Department of Statistics, USBE, Umeå University, Sweden; Joseph Harbison, Department of Medical Gerontology, University of Dublin, Trinity College, Dublin, Ireland; Tatiana Kharitonova,*Saint Petersburg Research Institute of Emergency Medicine, St Petersburg, Russia; Dilek Necioğlu Orken, Department of Neurology, Istanbul Bilim University, Istanbul, Turkey; Francesca Pezella, San Camillo-Forlanini Hospital, Rome, Italy; and Igor Voznuk, Saint Petersburg Research Institute of Emergency Medicine, St Petersburg, Russia. Translational research priorities:Anna Planas (Chair), Institut d'Investigacions Biomèdiques de Barcelona (IIBB), Consejo Superior de Investigaciones Científicas (CSIC), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Denis Vivien, Université Normandie, CHU de Caen Normandie, Caen, France; Stephanie Debette, Bordeaux Population Health Research Center and Department of Neurology, CHU de Bordeaux, Bordeaux, France;  Adam Denes, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary; Ulrich Dirnagl, Charite Universitätsmedizin Berlin and Berlin Insitute of Health, Berlin, Germany; Arthur Liesz, Institute for Stroke and Dementia Research, Klinikum der Universität München, Munich, Germany; Hugh Stephan Markus, Clinical Neuroscience, University of Cambridge, Cambridge, UK; and Geert Jan Biessels, Department of Neurology, University Medical Center Utrecht, Utrecht, the Netherlands . Life after stroke: Avril Drummond (Chair), School of Health Sciences, University of Nottingham, Nottingham, UK; Juliet Bouverie, Stroke Association, London, UK; Anne Gordon, Guy's & St Thomas' Hospital NHS Foundation Trust and King's College London, London, UK; Janika Kõrv,* Department of Neurology and Neurosurgery, University of Tartu, Tartu, Estonia; Charlotte Magnusson, Department of Design Sciences, Lund University, Lund, Sweden; Christopher McKevitt,* School of Population Health & Environmental Sciences, King's College,  London, UK; Harriet Proios, Department of Educational and Social Policy, University of Macedonia, Thessaloniki, Greece; Markus Wagner, Stroke Alliance For Europe, Brussels, Belgium; and Diana Wong, SAFE-Stroke Alliance for Europe, Lisbon, Portugal.

*Members responsible for defining research priorities.

Website by mzlaki logo Studio Mzlaki